Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Blackrock Health Sciences Trust (BME)

https://www.blackrock.com

Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/29/2005

Market Cap

574,004,760

Shares Outstanding

12,570,000

Weighted SO

13,943,973

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

EOS --.--%

CII --.--%

UTF --.--%

BST --.--%

STK --.--%

EOI --.--%

EXG --.--%

ETV --.--%

BCX --.--%

Beta

0.6690

Last Div

2.5600

Range

35.53-42.86

Chg

-0.2850

Avg Vol

33211

Mkt Cap

574004760

Exch

NYSE

Country

US

Phone

212 810 5300

DCF Diff

41.4466

DCF

-0.2816

Div Yield

0.0621

P/S

14.7209

EV Multiple

31.8722

P/FV

0.9760

Div Yield %

6.2092

P/E

15.1467

PEG

0.0864

Payout

1.3893

Current Ratio

26.7092

Quick Ratio

26.7092

Cash Ratio

0.0088

DSO

14.7589

DIO

0.0000

Op Cycle

14.7589

DPO

0.0000

CCC

14.7589

Gross Margin

0.8456

Op Margin

0.5391

Pretax Margin

0.2567

Net Margin

0.9719

Eff Tax Rate

0.8998

ROA

0.0636

ROE

0.0639

ROCE

0.0353

NI/EBT

3.7864

EBT/EBIT

0.4761

EBIT/Rev

0.5391

Debt Ratio

0.0002

D/E

0.0002

LT Debt/Cap

0.0001

Total Debt/Cap

0.0002

Int Coverage

382178.3091

CF/Debt

171.1594

Equity Multi

1.0135

Rec Turnover

24.7309

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0654

OCF/Share

1.4898

FCF/Share

1.4898

Cash/Share

2.2517

OCF/Sales

0.5328

FCF/OCF

1.0000

CF Coverage

171.1594

ST Coverage

342.3188

CapEx Coverage

0.0000

Div&CapEx Cov

0.3946

P/BV

0.9760

P/B

0.9760

P/S

14.7209

P/E

15.1467

P/FCF

27.6310

P/OCF

27.6310

P/CF

27.6310

PEG

0.0864

P/S

14.7209

EV Multiple

31.8722

P/FV

0.9760

DPS

2.5560

Latest Headlines (EST)

GlobeNewswire Inc. Jun 18, 03:15 Biomea Fusion Announces Pricing of Public Offering of Securities GlobeNewswire Inc. Mar 25, 23:00 Biomea Fusion Announces Leadership Transition GlobeNewswire Inc. Dec 16, 23:15 Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D) GlobeNewswire Inc. Jan 09, 11:02 Biomea Fusion Highlights Recent Updates and Anticipated 2024 Corporate Milestones at 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 11, 09:25 Biomea Fusion Presents Achievement of Minimal Residual Disease Negativity (MRD-neg) in First Complete Responder from Ongoing Phase I Study (COVALENT-101) of BMF-219 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) at the 2023 ASH GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 09, 17:30 Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts GlobeNewswire Inc. Dec 07, 09:15 Biomea Fusion to Present Long-Term Follow-Up Data from Ongoing Phase II Study (COVALENT-111) of BMF-219 in Adults with Type 2 Diabetes and Results from Ex-Vivo Human Islet Experiments at the World Congress Insulin Resistance, Diabetes & Cardiovascular Dis GlobeNewswire Inc. Dec 05, 08:30 Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 Diabetes GlobeNewswire Inc. Nov 27, 08:30 Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.21 07/15/2024 07/01/2024 07/15/2024 07/31/2024
0.21 06/14/2024 06/03/2024 06/14/2024 06/28/2024
0.21 05/14/2024 05/01/2024 05/15/2024 05/31/2024
0.21 04/12/2024 04/01/2024 04/15/2024 04/30/2024
0.21 03/14/2024 03/01/2024 03/15/2024 03/28/2024
0.21 02/14/2024 02/01/2024 02/15/2024 02/29/2024
0.21 01/11/2024 01/02/2024 01/12/2024 01/31/2024
0.21 12/14/2023 12/05/2023 12/15/2023 12/20/2023
0.21 11/14/2023 11/01/2023 11/15/2023 11/30/2023
0.21 10/13/2023 10/02/2023 10/16/2023 10/31/2023
0.21 09/14/2023 09/01/2023 09/15/2023 09/29/2023
0.21 08/14/2023 08/01/2023 08/15/2023 08/31/2023
0.21 07/13/2023 07/03/2023 07/14/2023 07/31/2023
0.21 06/14/2023 06/01/2023 06/15/2023 06/30/2023
0.21 05/12/2023 05/01/2023 05/15/2023 05/31/2023
0.21 04/13/2023 04/03/2023 04/14/2023 04/28/2023
0.21 03/14/2023 03/01/2023 03/15/2023 03/31/2023
0.21 02/14/2023 02/01/2023 02/15/2023 02/28/2023
0.21 01/12/2023 01/03/2023 01/13/2023 01/31/2023
0.21 12/15/2022 12/06/2022 12/16/2022 12/30/2022
0.21 11/14/2022 11/01/2022 11/15/2022 11/30/2022
0.21 10/13/2022 10/03/2022 10/14/2022 10/31/2022
0.21 09/14/2022 09/01/2022 09/15/2022 09/30/2022
0.21 08/12/2022 08/01/2022 08/15/2022 08/31/2022
0.21 07/14/2022 07/06/2022 07/15/2022 07/29/2022
0.21 06/14/2022 06/01/2022 06/15/2022 06/30/2022
0.21 05/13/2022 05/02/2022 05/16/2022 05/31/2022
0.21 04/13/2022 04/01/2022 04/14/2022 04/29/2022
0.21 03/14/2022 03/01/2022 03/15/2022 03/31/2022
0.21 02/14/2022 02/01/2022 02/15/2022 02/28/2022
0.21 01/13/2022 01/03/2022 01/14/2022 01/31/2022
0.21 12/16/2021 12/06/2021 12/17/2021 12/31/2021
0.21 11/12/2021 11/01/2021 11/15/2021 11/30/2021
0.21 10/14/2021 10/01/2021 10/15/2021 10/29/2021
0.20 09/14/2021 09/01/2021 09/15/2021 09/30/2021
0.20 08/13/2021 08/02/2021 08/16/2021 08/31/2021
0.20 07/14/2021 07/03/2021 07/15/2021 07/30/2021
0.20 06/14/2021 06/01/2021 06/15/2021 06/30/2021
0.20 05/13/2021 05/03/2021 05/14/2021 05/28/2021
0.20 04/14/2021 04/06/2021 04/15/2021 04/30/2021
0.20 03/12/2021 03/01/2021 03/15/2021 03/31/2021
0.20 02/12/2021 02/01/2021 02/16/2021 02/26/2021
0.20 01/14/2021 01/05/2021 01/15/2021 01/29/2021
0.20 12/14/2020 12/04/2020 12/15/2020 12/31/2020
0.20 11/13/2020 11/02/2020 11/16/2020 11/30/2020
0.20 10/14/2020 10/01/2020 10/15/2020 10/30/2020
0.20 09/14/2020 09/01/2020 09/15/2020 09/30/2020
0.20 08/13/2020 08/03/2020 08/14/2020 08/31/2020
0.20 07/14/2020 07/01/2020 07/15/2020 07/31/2020
0.20 06/12/2020 06/01/2020 06/15/2020 06/30/2020
0.20 05/14/2020 05/01/2020 05/15/2020 05/29/2020
0.20 04/14/2020 04/01/2020 04/15/2020 04/30/2020
0.20 03/13/2020 03/02/2020 03/16/2020 03/31/2020
0.20 02/13/2020 02/03/2020 02/14/2020 02/28/2020
0.20 01/14/2020 01/02/2020 01/15/2020 01/31/2020
0.20 12/13/2019 12/10/2019 12/16/2019 12/31/2019
0.20 11/14/2019 11/01/2019 11/15/2019 11/29/2019
0.20 10/11/2019 10/01/2019 10/15/2019 10/31/2019
0.20 09/13/2019 09/03/2019 09/16/2019 09/30/2019
0.20 08/14/2019 08/01/2019 08/15/2019 08/30/2019
0.20 07/12/2019 07/01/2019 07/15/2019 07/31/2019
0.20 06/13/2019 06/03/2019 06/14/2019 06/28/2019
0.20 05/14/2019 05/02/2019 05/15/2019 05/31/2019
0.20 04/12/2019 04/02/2019 04/15/2019 04/30/2019
0.20 03/14/2019 03/04/2019 03/15/2019 03/29/2019
0.20 02/14/2019 02/04/2019 02/15/2019 02/28/2019
0.20 01/14/2019 01/03/2019 01/15/2019 01/31/2019
0.20 12/14/2018 12/10/2018 12/17/2018 12/31/2018
0.20 11/14/2018 11/01/2018 11/15/2018 11/30/2018
0.20 10/12/2018 10/01/2018 10/15/2018 10/31/2018
0.20 09/13/2018 09/04/2018 09/14/2018 09/28/2018
0.20 08/14/2018 08/01/2018 08/15/2018 08/31/2018
0.20 07/13/2018 07/02/2018 07/16/2018 07/31/2018
0.20 06/14/2018 06/04/2018 06/15/2018 06/29/2018
0.20 05/14/2018 05/02/2018 05/15/2018 05/31/2018
0.20 04/13/2018 04/03/2018 04/16/2018 04/30/2018
0.20 03/14/2018 03/05/2018 03/15/2018 03/29/2018
0.20 02/14/2018 02/05/2018 02/15/2018 02/28/2018
0.20 01/12/2018 01/03/2018 01/16/2018 01/31/2018
0.20 12/15/2017 12/11/2017 12/18/2017 12/29/2017
0.20 11/14/2017 11/01/2017 11/15/2017 11/30/2017
0.20 10/13/2017 10/02/2017 10/16/2017 10/31/2017
0.20 09/14/2017 09/01/2017 09/15/2017 09/29/2017
0.20 08/11/2017 08/01/2017 08/15/2017 08/31/2017
0.20 07/12/2017 07/03/2017 07/14/2017 07/31/2017
0.20 06/13/2017 06/01/2017 06/15/2017 06/30/2017
0.20 05/11/2017 05/01/2017 05/15/2017 05/31/2017
0.20 04/11/2017 04/04/2017 04/13/2017 04/28/2017
0.20 03/13/2017 03/02/2017 03/15/2017 03/31/2017
0.20 02/13/2017 02/02/2017 02/15/2017 02/28/2017
0.20 01/11/2017 01/03/2017 01/13/2017 01/31/2017
0.80 12/15/2016 12/07/2016 12/19/2016 12/30/2016
0.20 11/10/2016 11/01/2016 11/15/2016 11/30/2016
0.20 10/12/2016 10/03/2016 10/14/2016 10/31/2016
0.20 09/13/2016 09/01/2016 09/15/2016 09/30/2016
0.20 08/11/2016 08/02/2016 08/15/2016 08/31/2016
0.20 07/13/2016 07/01/2016 07/15/2016 07/29/2016
0.20 06/13/2016 06/01/2016 06/15/2016 06/30/2016
0.20 05/12/2016 05/03/2016 05/16/2016 05/31/2016
0.20 04/13/2016 04/01/2016 04/15/2016 04/29/2016
0.20 03/11/2016 03/01/2016 03/15/2016 03/31/2016
0.20 02/11/2016 02/01/2016 02/16/2016 02/29/2016
0.20 01/13/2016 01/04/2016 01/15/2016 01/29/2016
4.55 12/16/2015 12/07/2015 12/18/2015 12/31/2015
0.20 11/12/2015 11/02/2015 11/16/2015 11/30/2015
0.20 10/13/2015 10/02/2015 10/15/2015 10/30/2015
0.20 09/11/2015 09/01/2015 09/15/2015 09/30/2015
0.20 08/12/2015 08/03/2015 08/14/2015 08/31/2015
0.16 07/13/2015 07/01/2015 07/15/2015 07/31/2015
0.16 06/11/2015 06/01/2015 06/15/2015 06/30/2015
0.16 05/13/2015 05/01/2015 05/15/2015 05/29/2015
0.16 04/13/2015 04/01/2015 04/15/2015 04/30/2015
0.16 03/11/2015 03/02/2015 03/13/2015 03/31/2015
0.16 02/11/2015 02/02/2015 02/13/2015 02/27/2015
0.16 01/13/2015 01/02/2015 01/15/2015 01/30/2015
2.37 12/18/2014 12/09/2014 12/22/2014 12/31/2014
0.16 11/12/2014 11/03/2014 11/14/2014 11/28/2014
0.50 10/10/2014 10/01/2014 10/15/2014 10/31/2014
0.14 09/11/2014 09/02/2014 09/15/2014 09/30/2014
0.43 06/12/2014 06/02/2014 06/16/2014 06/30/2014
0.43 03/12/2014 03/03/2014 03/14/2014 03/31/2014
1.91 12/18/2013 12/09/2013 12/20/2013 12/31/2013
0.38 09/12/2013 09/03/2013 09/16/2013 09/30/2013
0.38 06/12/2013 06/03/2013 06/14/2013 06/28/2013
0.38 03/13/2013 03/01/2013 03/15/2013 03/28/2013
1.23 12/19/2012 12/10/2012 12/21/2012 12/31/2012
0.38 09/12/2012 09/04/2012 09/14/2012 09/28/2012
0.38 06/13/2012 06/01/2012 06/15/2012 06/29/2012
0.38 03/13/2012 03/01/2012 03/15/2012 03/30/2012
1.35 12/16/2011 12/09/2011 12/20/2011 12/30/2011
0.38 09/13/2011 09/01/2011 09/15/2011 09/30/2011
0.38 06/13/2011 06/01/2011 06/15/2011 06/30/2011
0.38 03/11/2011 03/01/2011 03/15/2011 03/31/2011
1.08 12/17/2010 12/10/2010 12/21/2010 12/31/2010
0.38 09/13/2010 09/01/2010 09/15/2010 09/30/2010
0.38 06/11/2010 06/01/2010 06/15/2010 06/30/2010
0.38 03/11/2010 03/01/2010 03/15/2010 03/31/2010
0.38 12/18/2009 12/11/2009 12/22/2009 12/31/2009
0.38 09/11/2009 09/01/2009 09/15/2009 09/30/2009
0.38 06/11/2009 06/01/2009 06/15/2009 06/30/2009
0.38 03/12/2009 03/02/2009 03/16/2009 03/31/2009
0.56 12/18/2008 12/15/2008 12/22/2008 12/31/2008
0.38 09/11/2008 09/02/2008 09/15/2008 09/30/2008
0.38 06/12/2008 06/02/2008 06/16/2008 06/30/2008
0.38 03/12/2008 03/03/2008 03/14/2008 03/31/2008
0.92 12/18/2007 12/11/2007 12/20/2007 12/31/2007
0.38 09/12/2007 09/04/2007 09/14/2007 09/28/2007
0.38 06/13/2007 06/01/2007 06/15/2007 06/29/2007
0.38 03/13/2007 03/01/2007 03/15/2007 03/30/2007
0.38 12/13/2006 12/04/2006 12/15/2006 12/29/2006
0.77 09/13/2006 09/02/2006 09/15/2006 09/29/2006
0.38 06/13/2006 06/02/2006 06/15/2006 06/30/2006
0.38 03/13/2006 03/02/2006 03/15/2006 03/31/2006
0.38 12/13/2005 12/02/2005 12/15/2005 12/30/2005
0.38 09/13/2005 09/01/2005 09/15/2005 09/30/2005
0.38 06/13/2005 05/20/2005 06/15/2005 06/30/2005